fbpx

Science

Study Title
Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia
Publication
Neurology
Author(s)

Andrew J. Westwood, MD; Alexa Beiser, PhD; Nikita Jain
Jayandra J. Himali, PhD; Charles DeCarli, MD; Sanford H. Auerbach, MD; Matthew P. Pase, PhD; Sudha Seshadri, MD

Abstract

Objective: To evaluate the association between sleep duration and the risk of incident dementia and brain aging.
Methods: Self-reported total hours of sleep were examined in the Framingham Heart Study (n 5 2,457, mean age 72 6 6 years, 57% women) as a 3-level variable: ,6 hours (short), 6–9 hours (reference), and .9 hours (long), and was related to the risk of incident dementia over 10 years, and cross-sectionally to total cerebral brain volume (TCBV) and cognitive performance.
Results: We observed 234 cases of all-cause dementia over 10 years of follow-up. In multivariable analyses, prolonged sleep duration was associated with an increased risk of incident dementia (hazard ratio [HR] 2.01; 95% confidence interval [CI] 1.24–3.26). These findings were driven by persons with baseline mild cognitive impairment (HR 2.83; 95% CI 1.06–7.55) and persons without a high school degree (HR 6.05; 95% CI 3.00–12.18). Transitioning to sleeping .9 hours over a mean period of 13 years before baseline was associated with an increased risk of all-cause dementia (HR 2.43; 95% CI 1.44–4.11) and clinical Alzheimer disease (HR 2.20; 95% CI 1.17– 4.13). Relative to sleeping 6–9 hours, long sleep duration was also associated cross-sectionally with smaller TCBV (b 6 SE, 21.08 6 0.41 mean units of TCBV difference) and poorer executive function (b 6 SE, 20.41 6 0.13 SD units of Trail Making Test B minus A score difference).
Conclusions: Prolonged sleep duration may be a marker of early neurodegeneration and hence a useful clinical tool to identify those at a higher risk of progressing to clinical dementia within 10 years.

Date
March 21, 2017
View study

Share This

Related Topics

DementiaSleep

Dr. Perlmutter is one of the leading lights in medicine today, illuminating the path for solving chronic illness

Mark Hyman, MD